QuidelOrtho Corp (QDEL)
39.65
-0.04
(-0.10%)
USD |
NASDAQ |
Apr 26, 16:00
39.65
0.00 (0.00%)
After-Hours: 19:33
QuidelOrtho SG&A Expense (Quarterly): 187.60M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 187.60M |
September 30, 2023 | 194.10M |
June 30, 2023 | 179.10M |
March 31, 2023 | 202.40M |
December 31, 2022 | 213.60M |
September 30, 2022 | 204.20M |
June 30, 2022 | 118.40M |
March 31, 2022 | 84.80M |
December 31, 2021 | 73.70M |
September 30, 2021 | 63.00M |
June 30, 2021 | 54.20M |
March 31, 2021 | 53.74M |
December 31, 2020 | 58.40M |
September 30, 2020 | 53.82M |
June 30, 2020 | 43.25M |
March 31, 2020 | 45.07M |
December 31, 2019 | 42.30M |
September 30, 2019 | 38.74M |
June 30, 2019 | 39.80M |
March 31, 2019 | 43.02M |
December 31, 2018 | 38.68M |
September 30, 2018 | 37.12M |
June 30, 2018 | 39.04M |
March 31, 2018 | 39.09M |
December 31, 2017 | 35.08M |
Date | Value |
---|---|
September 30, 2017 | 20.17M |
June 30, 2017 | 19.85M |
March 31, 2017 | 21.34M |
December 31, 2016 | 20.45M |
September 30, 2016 | 18.22M |
June 30, 2016 | 18.64M |
March 31, 2016 | 19.61M |
December 31, 2015 | 19.60M |
September 30, 2015 | 18.00M |
June 30, 2015 | 18.21M |
March 31, 2015 | 21.65M |
December 31, 2014 | 18.37M |
September 30, 2014 | 17.28M |
June 30, 2014 | 15.24M |
March 31, 2014 | 17.15M |
December 31, 2013 | 18.34M |
September 30, 2013 | 14.28M |
June 30, 2013 | 13.02M |
March 31, 2013 | 15.97M |
December 31, 2012 | 12.32M |
September 30, 2012 | 12.54M |
June 30, 2012 | 12.81M |
March 31, 2012 | 12.46M |
December 31, 2011 | 12.42M |
September 30, 2011 | 11.68M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
38.74M
Minimum
Sep 2019
213.60M
Maximum
Dec 2022
102.64M
Average
63.00M
Median
Sep 2021
SG&A Expense (Quarterly) Benchmarks
Abbott Laboratories | 2.959B |
Becton Dickinson & Co | 1.213B |
Boston Scientific Corp | 1.379B |
Tenon Medical Inc | 3.009M |
Perspective Therapeutics Inc | 1.694M |